PROGESTERONE by Eli Lilly and Company is clinical pharmacology progesterone capsules are an oral dosage form of micronized progesterone which is chemically identical to progesterone of ovarian origin. First approved in 1974.
Drug data last refreshed 3h ago · AI intelligence enriched 4d ago
Progesterone is a micronized oral capsule formulation of progesterone, chemically identical to naturally occurring ovarian progesterone, designed to improve bioavailability through micronization technology. It is indicated for use in hormone replacement therapy (HRT), typically in combination with conjugated estrogens for postmenopausal women with an intact uterus. The drug works by providing exogenous progesterone to replace declining endogenous levels and protect the endometrium against estrogen-induced proliferation.
Product approaching loss of exclusivity with limited commercial runway; brand teams should expect resource reallocation and focus on generic transition planning.
CLINICAL PHARMACOLOGY Progesterone capsules are an oral dosage form of micronized progesterone which is chemically identical to progesterone of ovarian origin. The oral bioavailability of progesterone is increased through micronization. Pharmacokinetics A. Absorption After oral administration of…
Worked on PROGESTERONE at Eli Lilly and Company? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Individualized Prolonged Luteal Support After Fresh Embryo Transfer in Women With Low Progesterone
Cycle-to-cycle Variability of Progesterone in the Endometrium in Patients Undergoing an Euploid Blastocyst Transfer in a Hormone Replacement Therapy (HRT) Cycle (PROMICOFET)
Comparing the Pharmacokinetics of a Progesterone Ring Versus a Progesterone Vaginal Insert
Exogenous Progesterone as Ovulation Trigger
Comparison of Two Vaginal Progesterone Forms in Frozen Embryo Transfer
Eli Lilly and Company is hiring 2 roles related to this product
Roles linked to this product are heavily clinical rather than commercial, reflecting its mature market status and focus on patient management in primary care settings. Career progression is limited; positions are primarily in clinical support and nursing practice rather than brand management or commercial strategy.
2 open roles linked to this drug